1
Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:August 29, 2019Recruiting
Cholangiocarcinoma: 541 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
Fluorescence Image Guided Surgery in Cholangiocarcinoma
Condition(s):Hilar CholangiocarcinomaLast Updated:October 3, 2019Recruiting
3
Long-term Morbidity After Surgery for Perihilar Cholangiocarcinoma
Condition(s):Cholangiocarcinoma; Surgery–ComplicationsLast Updated:June 26, 2019Completed
4
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:April 12, 2017Completed
5
ncRNAs in Exosomes of Cholangiocarcinoma
Condition(s):Cholangiocarcinoma; Benign Biliary StrictureLast Updated:March 30, 2017Recruiting
6
Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:August 15, 2018Active, not recruiting
7
Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 30, 2016Unknown status
8
A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma
Condition(s):Unresectable and Advanced CholangiocarcinomaLast Updated:January 30, 2017Completed
9
Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:February 23, 2019Suspended
10
Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:February 2, 2012Unknown status
11
Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Condition(s):Cholangiocarcinoma, IntrahepaticLast Updated:May 14, 2019Recruiting
12
Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:July 8, 2014Unknown status
13
RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma
Condition(s):Hilar Cholangiocarcinoma; Intrahepatic CholangiocarcinomaLast Updated:October 24, 2017Completed
14
Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma
Condition(s):Cholangiocarcinoma, IntrahepaticLast Updated:September 3, 2019Not yet recruiting
15
Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
Condition(s):Advanced Intrahepatic CholangiocarcinomaLast Updated:December 23, 2009Unknown status
16
Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors
Condition(s):CholangiocarcinomaLast Updated:September 22, 2016Recruiting
17
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:September 3, 2019Not yet recruiting
18
Toripalimab Combined With Gemcitabine/5–fluoropyrimidine for Advanced Cholangiocarcinoma
Condition(s):Advanced CholangiocarcinomaLast Updated:July 13, 2019Recruiting
19
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:April 23, 2018Completed
20
S-1 and Photodynamic Therapy in Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:February 5, 2014Completed
21
Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:October 8, 2019Recruiting
22
Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma
Condition(s):Cholangiocarcinoma; Bile Duct CancerLast Updated:September 25, 2019Recruiting
23
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:May 7, 2018Completed
24
Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma
Condition(s):Bile Duct Cancer; Intrahepatic Cholangiocarcinoma; Cholangiocarcinoma of the Extrahepatic Bile DuctLast Updated:December 12, 2016Completed
25
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Condition(s):Unresectable Intrahepatic Cholangiocarcinoma; Resectable Intrahepatic CholangiocarcinomaLast Updated:April 11, 2016Terminated
26
Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Condition(s):CholangiocarcinomaLast Updated:September 8, 2009Unknown status
27
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:June 24, 2018Active, not recruiting
28
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:April 18, 2019Recruiting
29
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:July 31, 2017Active, not recruiting
30
International Registry on Cholangiocarcinoma Treatment
Condition(s):CholangiocarcinomaLast Updated:February 26, 2019Recruiting
31
Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
Condition(s):CholangiocarcinomaLast Updated:May 1, 2017Withdrawn
32
Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
Condition(s):Hilar CholangiocarcinomaLast Updated:June 26, 2014Unknown status
33
Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Condition(s):CholangiocarcinomaLast Updated:July 15, 2019Recruiting
34
Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:August 6, 2019Recruiting
35
RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy
Condition(s):CholangiocarcinomaLast Updated:June 4, 2018Active, not recruiting
36
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy – (FIGHT-202)
Condition(s):CholangiocarcinomaLast Updated:August 16, 2019Recruiting
37
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma – (FIGHT-302)
Condition(s):Unresectable Cholangiocarcinoma; Metastatic CholangiocarcinomaLast Updated:October 11, 2019Recruiting
38
A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:February 15, 2018Withdrawn
39
Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
Condition(s):Unresectable Hilar CholangiocarcinomaLast Updated:September 3, 2008Unknown status
40
Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma
Condition(s):Cholangiocarcinoma, Perihilar; SurgeryLast Updated:December 22, 2017Recruiting
41
90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:May 28, 2019Recruiting
42
Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
Condition(s):Advanced CholangiocarcinomaLast Updated:May 16, 2019Terminated
43
Surgery for Recurrent Intrahepatic Cholangiocarcinoma
Condition(s):Cholangiocarcinoma, Intrahepatic; Recurrence Cholangiocarcinoma; Re-hepatectomyLast Updated:September 11, 2019Completed
44
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:February 17, 2017Completed
45
Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
Condition(s):Hilar CholangiocarcinomaLast Updated:July 15, 2019Terminated
46
Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:August 25, 2008Completed
47
VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)
Condition(s):Extrahepatic CholangiocarcinomaLast Updated:March 31, 2014Unknown status
48
Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
Condition(s):Hilar CholangiocarcinomaLast Updated:July 31, 2019Recruiting
49
Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 30, 2016Unknown status
50
Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:August 20, 2018Recruiting
51
VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:August 5, 2013Unknown status
52
Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:September 11, 2015Unknown status
53
A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma
Condition(s):Unresectable Intrahepatic CholangiocarcinomaLast Updated:October 24, 2017Recruiting
54
A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:May 9, 2018Recruiting
55
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:March 9, 2017Completed
56
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:September 5, 2018Completed
57
Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:December 17, 2018Completed
58
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
Condition(s):CholangiocarcinomaLast Updated:May 24, 2018Completed
59
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Condition(s):CholangiocarcinomaLast Updated:October 28, 2019Completed
60
Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
Condition(s):Advanced Cholangiocarcinoma; FGFR2 Gene MutationLast Updated:April 26, 2019Recruiting
61
Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:April 14, 2016Terminated
62
Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:February 25, 2013Unknown status
63
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Condition(s):Advanced Cholangiocarcinoma; FGFR2 Gene MutationLast Updated:October 12, 2019Recruiting
64
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:May 17, 2016Recruiting
65
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:February 1, 2018Completed
66
Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic Cholangiocarcinoma; Combined Hepatocellular and CholangiocarcinomaLast Updated:October 18, 2019Recruiting
67
Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Condition(s):Cholangiocarcinoma; Drainage; SurgeryLast Updated:November 24, 2008Unknown status
68
Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma
Condition(s):Hilar CholangiocarcinomaLast Updated:April 17, 2018Recruiting
69
Liver Transplantation for Early Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:May 28, 2018Recruiting
70
TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:March 30, 2016Unknown status
71
Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
Condition(s):Cholangiocarcinoma; Gallbladder CancerLast Updated:August 9, 2013Completed
72
Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:August 21, 2019Not yet recruiting
73
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
Condition(s):CholangiocarcinomaLast Updated:January 6, 2010Completed
74
PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer
Condition(s):CholangiocarcinomaLast Updated:November 5, 2019Recruiting
75
Regorafenib Versus Placebo to Treat Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:March 19, 2019Active, not recruiting
76
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
Condition(s):CholangiocarcinomaLast Updated:March 9, 2017Completed
77
Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:June 29, 2014Completed
78
A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Condition(s):Metastatic Biliary Tract CarcinomaLast Updated:January 9, 2019Completed
79
SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:October 23, 2019Active, not recruiting
80
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
Condition(s):Hilar CholangiocarcinomaLast Updated:August 14, 2019Terminated
81
Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:August 9, 2012Withdrawn
82
A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:April 3, 2018Terminated
83
Liver Transplantation for Cholangiocarcinoma
Condition(s):Cancer; Cholangiocarcinoma; LiverLast Updated:July 23, 2013Terminated
84
Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples
Condition(s):Intrahepatic Cholangiocarcinoma; Mixed Hepatocellular Cholangiocarcinoma; CholangiocarcinomaLast Updated:June 7, 2017Completed
85
Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)
Condition(s):Advanced Cholangiocarcinoma; Metastatic CholangiocarcinomaLast Updated:October 9, 2019Active, not recruiting
86
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Condition(s):Bile Duct Cancer; Intrahepatic CholangiocarcinomaLast Updated:July 18, 2018Recruiting
87
Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:June 1, 2015Terminated
88
Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma
Condition(s):Hilar CholangiocarcinomaLast Updated:November 21, 2011Completed
89
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Condition(s):CholangiocarcinomaLast Updated:January 1, 2018Completed
90
Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma
Condition(s):Hepatocellular Carcinoma; Intrahepatic CholangiocarcinomaLast Updated:May 10, 2018Suspended
91
Toripalimab or Placebo as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Condition(s):Epatocellular Carcinoma, Intrahepatic CholangiocarcinomaLast Updated:October 21, 2019Not yet recruiting
92
Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Condition(s):Unresectable Cholangiocarcinoma; Biliary Obstruction; Stent Obstruction; Biliary StrictureLast Updated:February 16, 2017Unknown status
93
Treatment for Bile Duct Cancer in the Liver
Condition(s):Cholangio CarcinomaLast Updated:February 25, 2019Recruiting
94
Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:March 20, 2014Unknown status
95
Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:July 1, 2019Recruiting
96
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma
Condition(s):Cholangiocarcinoma; Biliary Tract Cancer; Adjuvant Chemotherapy; Capecitabine; Gemcitabine; CisplatinLast Updated:September 18, 2017Recruiting
97
Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
Condition(s):Cholangiocarcinoma Non-resectable; Non-metastaticLast Updated:November 30, 2017Not yet recruiting
98
A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma
Condition(s):Intrahepatic Cholangiocarcinoma; Second-line TreatmentLast Updated:July 12, 2019Completed
99
Trial of IRE in Cholangiocarcinoma
Condition(s):CholangiocarcinomaLast Updated:April 12, 2019Recruiting
100
Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas
Condition(s):CholangiocarcinomaLast Updated:February 3, 2010Terminated